Clinical Trial Detail

NCT ID NCT03114319
Title Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors Novartis Pharmaceuticals
Indications

Advanced Solid Tumor

Therapies

TNO155

Age Groups: senior adult

Additional content available in CKB BOOST